A comparison of 2 different medicated ointments with placebo for pain relief after banding of haemorrhoids.
- Conditions
- haemorrhoidsOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
- Registration Number
- ACTRN12620000044921
- Lead Sponsor
- Hunter New England Local Health District
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 99
Patients aged 18 years and over who present to the colorectal outpatient clinic or the private rooms of participating surgeons with symptomatic haemorrhoids suitable for banding will be considered for inclusion and offered study information.
A person will be excluded if they have the following:
• Coexisting anorectal disease such as anal fissure, fistula in ano, perianal abscess, thrombosed haemorrhoids, or colorectal malignancy
• A current medical history of uncontrolled ischemic heart disease, heart block, pregnancy or currently breastfeeding, severe hypertension (systolic blood pressure greater than 180mmHg), or orthostatic hypotension
• Poor general condition (i.e ASA classification 4 or 5)
• Allergy or sensitivity to diltiazem, lignocaine or polyethylene glycol (PEG) USP ointment base
• Current calcium channel blocker use
• Known side effects from previous calcium channel blocker use
• Refuse or are unable to give written informed consent to participate in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain scores between the 3 arms will be assessed using a standardised 10-point patient reported continuous visual analogue scale (zero represented no pain at all, and ten represented the severest pain imaginable)[• 30 minutes<br>• 1 hour<br>• 6 hours<br>• 12 hours<br>• 24 hours<br>• 48 hours]
- Secondary Outcome Measures
Name Time Method